BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update
by Teresa Graham · The Cerbat GemBlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) saw a significant decline in short interest during the month of January. As of January 30th, there was short interest totaling 8,067 shares, a decline of 93.6% from the January 15th total of 126,819 shares. Based on an average daily volume of 392,314 shares, the short-interest ratio is currently 0.0 days. Based on an average daily volume of 392,314 shares, the short-interest ratio is currently 0.0 days.
BlackRock Health Sciences Term Trust Stock Down 0.1%
Shares of NYSE:BMEZ traded down $0.02 during trading hours on Tuesday, hitting $15.05. 191,551 shares of the company’s stock traded hands, compared to its average volume of 343,665. The business has a fifty day moving average price of $15.26 and a 200-day moving average price of $14.81. BlackRock Health Sciences Term Trust has a 1 year low of $12.58 and a 1 year high of $16.20.
BlackRock Health Sciences Term Trust Dividend Announcement
The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 13th will be given a $0.11 dividend. This represents a c) annualized dividend and a yield of 8.8%. The ex-dividend date of this dividend is Friday, March 13th.
Insider Transactions at BlackRock Health Sciences Term Trust
In other BlackRock Health Sciences Term Trust news, Director Robert W. Fairbairn sold 10,294 shares of BlackRock Health Sciences Term Trust stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $14.98, for a total value of $154,204.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Institutional Trading of BlackRock Health Sciences Term Trust
Several institutional investors and hedge funds have recently made changes to their positions in the business. Blue Bell Private Wealth Management LLC purchased a new position in shares of BlackRock Health Sciences Term Trust during the third quarter worth approximately $1,290,000. Wolverine Asset Management LLC grew its stake in BlackRock Health Sciences Term Trust by 5,782.1% in the third quarter. Wolverine Asset Management LLC now owns 224,518 shares of the company’s stock worth $3,238,000 after purchasing an additional 220,701 shares in the last quarter. Shaker Financial Services LLC purchased a new position in BlackRock Health Sciences Term Trust during the 3rd quarter worth $2,654,000. Truist Financial Corp raised its position in BlackRock Health Sciences Term Trust by 5.9% during the 2nd quarter. Truist Financial Corp now owns 19,645 shares of the company’s stock valued at $280,000 after purchasing an additional 1,093 shares in the last quarter. Finally, Apollon Wealth Management LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust in the 2nd quarter worth $341,000.
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.